News | Breast Imaging | November 02, 2020

Beaumont Researchers Advise Breast Cancer Screening by Age 40 or Younger for Black Women

Murray Rebner, M.D., performing a breast ultrasound. Image courtesy of Beaumont Health

Murray Rebner, M.D., performing a breast ultrasound. Image courtesy of Beaumont Health

November 2, 2020 — Though Black women get breast cancer at a 3% lower incidence rate than white women, they are 42% more likely to die of breast cancer than white women. Wait a minute! That doesn’t make sense. Isn’t the death rate from breast cancer on a downward trend?

“We were astounded by this huge difference. The Black Lives Matter movement and equality marches inspired our research to provide better care for African American women,” said Murray Rebner, M.D., a Beaumont diagnostic radiologist who specializes in breast imaging. “My research partner, Vidya Pai, M.D., and I started to look deeply into the data to find out the reasons for this disturbing racial disparity to see if we could do anything that could save more lives of African American women.”

The physicians focused on how Black women dealt with getting screened and unique issues relevant to them. They revealed their findings recently in the Journal of Breast Imaging. Facts from “Breast Cancer Screening Recommendations: African American Women Are at a Disadvantage” include:

  1. Black women are more likely than white women to be diagnosed with breast cancer before the age of 50. Studies show 23% of breast cancers in Black women are diagnosed before age 50 compared to 16% of all breast cancers in white women.
  2. BRCAgenetic mutations are more common in Black women than in white women, although less frequent those of Ashkenazi Jewish ancestry.
  3. The triple-negative breast cancer subtype is more common among Black women. This subtype is aggressive but can have features that overlap with benign conditions like noncancerous breast lumps.
  4. Because of the higher incidence of aggressive breast cancer at a younger age, Black women might be disadvantaged by recommendations to start doing screening mammography at age 50.

Earlier breast screening gives Black women the most benefit

Screening guidelines are important because they guide doctors' recommendations and can determine if screening is covered by insurance. Breast cancer screening guidelines that recommend an older age to start screenings disadvantage Black women because they ignore key facts about their heightened risk at younger ages.

Rebner explained, “What’s even more concerning is African American women are much more likely to get a very aggressive triple negative breast cancer, which grows and spreads faster, has limited treatment options and a worse outcome. Triple negative breast cancer makes up 21% of the cases in African American women compared to 10% in white women.”

Rebner continued, “Fact one is earlier onset. Fact two is a more aggressive cancer type. Therefore, Dr. Pai and I conclude African American women need to be screened earlier, starting at least by age 40, and need to be screened yearly.”

“If African American women’s lives are to be saved, these aggressive breast cancers must be diagnosed and treated early,” said Rebner. “Heightening their risk is the BRCA2 genetic mutation, which dramatically raises the risk of breast cancer and is more common in African American women compared to non-Ashkenazi Jewish white women.”

Black women: Push for earlier screening

“Dr. Pai and I urge all women to take responsibility for their own health. Be aware of your own risks and feel empowered to discuss your risk of breast cancer and when and how often to get screened with your doctor,” advised Rebner.

But, what if you don’t have a doctor? It’s important for any woman to establish a relationship with a primary care doctor, who meets your needs and with whom you feel comfortable sharing very personal information. This could be a family medicine physician, gynecologist or internal medicine physician. Help finding a primary care doctor may be found here.

While it’s never too early for women to take a self-guided health risk assessment. Rebner recommends doing this by age 30, if you’re on the young side, or at any age if you’re older than 30. Click here for Beaumont’s free breast cancer risk assessment tool.

For more information: www.beaumont.org

Related Content

Radiologists have recently taken on the role of activists and are tackling pressing issues in healthcare, including breast density

Getty Images

Feature | Women's Health | January 20, 2021 | By Fazila Seker, Ph.D.
Radiologists — who have long been professionals in the metaphorical and literal back-rooms of healthcare — have recen
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next
Previously approved by FDA in the USA, MyLab X8 expands the reach of the MyLab Ultrasound Product Line with a fully featured premium imaging solution, integrating the latest technologies and delivering superior image quality without compromising workflow or efficiency.
News | Ultrasound Imaging | January 20, 2021
January 20, 2021 — Esaote North America announces that the...
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
January 15, 2021 — In one of the first studies to examine the impact of the...
A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant the

A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant therapy shows new mass (arrow) in upper outer left breast that was assessed as BI-RADS 4. Pathologic examination from MRI-guided core biopsy of new suspicious mass revealed benign usual ductal hyperplasia. No atypia or malignancy was identified. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | MRI Breast | January 15, 2021
January 15, 2021 — According to ARRS' ...
A targeted intervention providing mammograms to hospitalized Medicaid patients can help patients complete overdue breast cancer screening

Getty Images

News | Mammography | January 14, 2021
January 14, 2021 — Completing cancer screening tests, such as...
DB-I website features new educational tools and streamlined user experience to improve access to medically sourced breast density content
News | Breast Density | January 13, 2021
January 13, 2021 — DenseBreast-info.org (DB-I) invites he
This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately
News | Mammography | January 12, 2021
January 12, 2021 — Therapixel announced that...